Evaluation of effects of enteral nutrient enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants in patients underwent radical surgery for thoracic esophageal cancer.
Phase 2
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000002659
- Lead Sponsor
- Osaka City University Hospital, Second Department of Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Palliative and Emergency esophagectomy case Patients with severe immunosuppression Patients with cardiac, liver, or renal failure Patients with abnormal amino acid metabolism Known allergy of milk protein and lactose intolerance Patients assessed to be unsuitable for inclusion the study or enteral feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement in oxygenation condition(PaO2/ FiO2 ratio)
- Secondary Outcome Measures
Name Time Method acute inflammatory reaction transition of maximum body temperature body composition analysis perioperative complication length of post operative hospitalization